Abstract
Introduction Urbanization is associated with major changes in environmental and lifestyle exposures that may influence metabolic signatures. Objectives We investigated cross-sectional urban and rural differences in plasma metabolome analyzed by liquid chromatography/mass spectrometry platform in 500 Chinese adults aged 25–68 years from two neighboring southern Chinese provinces. Methods We first examined the overall metabolome differences by urban and rural residential location, using Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) and random forest classification. We then tested the association between urbanization status and individual metabolites using a linear regression adjusting for age, sex, and province and conducted pathway analysis (Fisher’s exact test) to identify metabolic pathways differed by urbanization status. Results We observed distinct overall metabolome by urbanization status in OPLS-DA and random forest classification. Using linear regression, out of a total of 1108 unique metabolite features identified in this sample, we found that 266 metabolites were differed by urbanization status (positive false discovery rate-adjusted p-value, q-value < 0.05). For example, the following metabolites were positively associated with urbanization status: caffeine metabolites from xanthine metabolism, hazardous pollutants like 4-hydroxychlorothalonil and perfluorooctanesulfonate, and metabolites implicated in cardiometabolic diseases, such as branched-chain amino acids. In pathway analysis, we found that xanthine metabolism pathways differed by urbanization status (q-value = 1.64E−04). Conclusion We detected profound differences in host metabolites by urbanization status. Urban residents were characterized by metabolites signaling caffeine metabolism and toxic pollutants and metabolites on known pathways to cardiometabolic disease risks, compared to their rural counterparts. Our findings highlight the importance of considering urbanization in metabolomics analysis.
Funding Information
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK104371)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD30880, P2C HD050924)
  • Fogarty International Center (D43 TW009077)
  • National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (UL1TR002489)
  • Sanofi (29230-50347-466001)
  • National Heart, Lung, and Blood Institute (T32HL129982)

This publication has 45 references indexed in Scilit: